Capstone Headwaters has released its August Pharmaceutical Outsourcing M&A Report, available for download below. The pandemic has emphasized the need for the industry to rethink its reliance on offshore manufacturing and complex global supply chains, as well as how to utilize technology to adopt a more decentralized approach to conducting clinical trials. While COVID-19 has certainly challenged contract research organizations (CROs) in administration of on-site activities and clinical trials, it has also fostered heightened innovation and implementation of remote technology. Virtual trials and eClinical solutions have gained increased adoption as CROs seek creative options for decentralized management of clinical trials.
Report contents include:
To learn more about the report, please reach out to Managing Director, Eric Williams.
Get instant access to reports like this as they're published. Subscribe